Abstract
AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a lipid-enveloped virus that acquires its lipid bilayer from the host cell it infects. SARS-CoV-2 can spread from cell to cell or from patient to patient by undergoing assembly and budding to form new virions. The assembly and budding of SARS-CoV-2 is mediated by several structural proteins known as envelope (E), membrane (M), nucleoprotein (N) and spike (S), which can form virus-like particles (VLPs) when co-expressed in mammalian cells. Assembly and budding of SARS-CoV-2 from the host ER-Golgi intermediate compartment is a critical step in the virus acquiring its lipid bilayer. To date, little information is available on how SARS-CoV-2 assembles and forms new viral particles from host membranes. In this study, we find the N protein can strongly associate with anionic lipids including phosphoinositides and phosphatidylserine. Moreover, lipid binding is shown to occur in the N protein C-terminal domain, which is supported by extensivein silicoanalysis. Anionic lipid binding occurs for both the free and N oligomeric forms suggesting N can associate with membranes in the nucleocapsid form. Herein we present a lipid-dependent model based onin vitro, cellular andin silicodata for the recruitment of N to M assembly sites in the lifecycle of SARS-CoV-2.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. “GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers;oftwareX,2015
2. Host Cell Plasma Membrane Phosphatidylserine Regulates the Assembly and Budding of Ebola Virus
3. Akinosoglou, K. , G. Schinas and C. Gogos (2022). “Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir.” Viruses 14(11).
4. Aleem, A. , A. B. Akbar Samad and S. Vaqar (2023). Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19). StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Abdul Bari Akbar Samad declares no relevant financial relationships with ineligible companies. Disclosure: Sarosh Vaqar declares no relevant financial relationships with ineligible companies., StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.
5. The Nucleoprotein Is Required for Efficient Coronavirus Genome Replication